tiprankstipranks
Protagenic Therapeutics (PTIX)
OTHER OTC:PTIX
US Market
PTIX
Protagenic Therapeutics
RESEARCH TOOLSreports

Protagenic Therapeutics (PTIX) Financial Statements

95 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently $1.25M. The company's EPS TTM is $-15.832; its P/E ratio is 0.28; Protagenic Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -37.72K$ -50.29K$ -28.22K$ -30.00$ 0.00
Operating Income$ -5.83M$ -5.70M$ -4.53M$ -3.56M$ -4.14M
EBITDA$ -8.02M$ -5.47M$ -4.50M$ -3.42M$ -4.14M
Net Income$ -5.16M$ -5.53M$ -5.00M$ -3.56M$ -4.52M
Balance Sheet
Cash & Short-Term Investments$ 2.21M$ 1.84M$ 4.06M$ 7.98M$ 10.37M
Total Assets$ 2.13M$ 1.96M$ 4.32M$ 8.04M$ 11.06M
Total Debt$ 3.16M$ 0.00$ 0.00$ 344.23K$ 318.43K
Net Debt$ 943.26K$ -1.84M$ -1.29M$ 129.04K$ -222.74K
Total Liabilities$ 6.82M$ 942.76K$ 655.25K$ 1.12M$ 1.12M
Stockholders' Equity$ -2.39M$ 1.01M$ 3.67M$ 6.92M$ 9.94M
Cash Flow
Free Cash Flow$ -4.14M$ -4.22M$ -3.85M$ -2.00M$ -2.80M
Operating Cash Flow$ -4.14M$ -4.22M$ -3.70M$ -1.99M$ -2.80M
Investing Cash Flow$ 943.18K$ 2.80M$ 4.78M$ 1.60M$ -9.91M
Financing Cash Flow$ 4.51M$ 1.96M$ 0.00$ 0.00$ 12.58M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Income Statement >

Protagenic Therapeutics Debt to Assets

Balance Sheet >

Protagenic Therapeutics Cash Flow

Cash Flow >

Protagenic Therapeutics Forecast EPS vs Actual EPS

Earnings >